Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_assertion description "[Patients with hypermethylated IGF2 in blood leukocyte DNA showed a significantly better survival rate than those with hypomethylated IGF2, indicating that the IGF2 methylation level in blood leukocyte DNA can be a possible marker not only of the risk for but also of the prognosis of gastric cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_assertion evidence source_evidence_literature NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_assertion SIO_000772 22447362 NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_assertion wasDerivedFrom befree-20140225 NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_assertion wasGeneratedBy ECO_0000203 NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.
- befree-20140225 importedOn "2014-02-25" NP376327.RA5vs5byTCKlUofoTBSvS43LDfEw2qgp7oeKDc_7wwe10130_provenance.